Scopus BioPharma Statistics

Total Valuation

Scopus BioPharma has a market cap or net worth of 12,625. The enterprise value is -1.40 million.

Market Cap	12,625
Enterprise Value	-1.40M

Important Dates

The next estimated earnings date is Friday, March 28, 2025.

Earnings Date	Mar 28, 2025
Ex-Dividend Date	n/a

Share Statistics

Scopus BioPharma has 42.08 million shares outstanding.

Current Share Class	n/a
Shares Outstanding	42.08M
Shares Change (YoY)	n/a
Shares Change (QoQ)	+30.86%
Owned by Insiders (%)	15.47%
Owned by Institutions (%)	n/a
Float	34.22M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
PB Ratio	n/a
P/TBV Ratio	n/a
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	0.16
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 0.05

Current Ratio	0.05
Quick Ratio	0.03
Debt / Equity	n/a
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	n/a

Financial Efficiency

Return on Equity (ROE)	n/a
Return on Assets (ROA)	-538.06%
Return on Capital (ROIC)	n/a
Revenue Per Employee	n/a
Profits Per Employee	-668,910
Employee Count	13
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -91.43% in the last 52 weeks. The beta is 36.49, so Scopus BioPharma's price volatility has been higher than the market average.

Beta (5Y)	36.49
52-Week Price Change	-91.43%
50-Day Moving Average	0.00
200-Day Moving Average	0.00
Relative Strength Index (RSI)	47.63
Average Volume (20 Days)	3,671

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	0.63

Income Statement

Revenue	n/a
Gross Profit	n/a
Operating Income	-9.34M
Pretax Income	-9.34M
Net Income	-8.70M
EBITDA	-9.34M
EBIT	-9.34M
Earnings Per Share (EPS)	-0.31

Full Income Statement

Balance Sheet

Cash & Cash Equivalents	362,097
Total Debt	n/a
Net Cash	362,097
Net Cash Per Share	0.01
Equity (Book Value)	-10.50M
Book Value Per Share	-0.24
Working Capital	-10.51M

Full Balance Sheet

Cash Flow

Operating Cash Flow	-3.04M
Capital Expenditures	n/a
Free Cash Flow	n/a
FCF Per Share	n/a

Full Cash Flow Statement

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

Scopus BioPharma does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-41.03%
Shareholder Yield	-41.03%
Earnings Yield	-68,877.81%
FCF Yield	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Altman Z-Score	n/a
Piotroski F-Score	n/a